21 U.S.C. § 829a
Delivery of a controlled substance by a pharmacy to an administering practitioner
United States · Title 21 — FOOD AND DRUGS · Status: effective
Cite this
- Citation
- 21 U.S.C. § 829a, Delivery of a controlled substance by a pharmacy to an administering practitioner, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/454628
- Permanent ID
ys:prov:454628@1- SHA-256
492133278e2193a2823f33ae37ae90fe7656c552d88a806c9563380223de7476
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Notwithstanding section 802(10) of this title, a pharmacy may deliver a controlled substance to a practitioner in accordance with a prescription that meets the requirements of this subchapter and the regulations issued by the Attorney General under this subchapter, for the purpose of administering the controlled substance by the practitioner if—
the controlled substance is a drug in schedule III, IV, or V to be administered—
During the 2-year period beginning on October 24, 2018, the Attorney General, in coordination with the Secretary, may reduce the number of days described in subsection (a)(5) if the Attorney General determines that such reduction will—
After the date on which the report described in section 3204(b) of the SUPPORT for Patients and Communities Act is submitted, the Attorney General, in coordination with the Secretary, may modify the number of days described in subsection (a)(5).
Any modification under this subsection shall be for a period of not less than 7 days.
Legislative history
The public laws that enacted or amended this section. Tallies are for the whole bill as it passed each chamber — often an omnibus covering far more than this provision — not a vote on this section alone. The law that originally enacted this section predates the public laws loaded here, so only later amendments are listed.
- SUPPORT for Patients and Communities Act
- Medical Marijuana and Cannabidiol Research Expansion ActHouse: 325–95Senate: no recorded tally
- Consolidated Appropriations Act, 2023House: 225–201Senate: no recorded tally
- HALT Fentanyl Act
- SUPPORT for Patients and Communities Reauthorization Act of 2025House: 366–57Senate: no recorded tally